Sage Journals: Discover world-class research

Abstract

In a two-study project, researchers used qualitative methods and inductive thematic analyses to investigate the lived awareness- and advocacy-related experiences of 27 adults with over 35 different rare diseases, disorders, or disabilities (RDs). In Study 1, participants in two focus groups described how a lack of RD awareness led to experiences with several types of stigma, complicated their expressions and disclosures of disability, and spurred them to work towards awareness. Participant priorities identified in Study 1 motivated researchers to design and conduct Study 2. In Study 2, researchers interviewed 18 RD self-advocates about their lived experiences with and ideas regarding advocacy. Their recommendations included increasing social and systemic support, education, and media and professional representation. Advocates in Study 2 also warned of potential roadblocks to self-advocacy and change, including systemic invalidation and bias, lack of access to activist spaces, and limited time and energy for advocacy. Overall, analyses exposed the complex and interwoven influences of RD awareness and advocacy.

Keywords

rare disease rare disorder disability advocacy advocate awareness stigma disclosure qualitative research thematic analysis

Get full access to this article

View all access options for this article.

References

Adama

E. A.

Arabiat

Foster

M. J.

Afrifa-Yamoah

Runions

Vithiatharan

Lin

(2021). The psychosocial impact of rare diseases among children and adolescents attending mainstream schools in Western Australia. International Journal of Inclusive Education, Advance online publication. https://doi.org/10.1080/13603116.2021.1888323

Adler

J. M.

Lakmazaheri

O’Brien

Palmer

Reid

Tawes

(2019). Identity integration in people with acquired disabilities: A qualitative study. Journal of Personality, 89(1), 1–29. https://doi.org/10.1111/jopy.12533

American Psychological Association . (2018). Discrimination: What it is, and how to cope. May 13, 2021. https://www.apa.org/topics/racism-bias-discrimination/types-stress

Americans With Disabilities Act . (1990). 42 U.S.C. § 12101 et seq. https://www.ada.gov/pubs/adastatute08.htm

Bogart

K. R.

Irvin

V. L.

(2017). Health-related quality of life among adults with diverse rare disorders. Orphanet Journal of Rare Diseases, 12(177). https://doi.org/10.1186/s13023-017-0730-1

Bradley

(2021). From biosociality to biosolidarity: The looping effects of finding and forming social networks for body-focused repetitive behaviors, 1080/1364. Anthropology & Medicine, 28(4), 543–557. https://doi.org/10.1080/13648470.2020.1864807

Braun

Clarke

(2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa

Brekke

O. A.

Sirnes

(2011). Biosociality, biocitizenship and the new regime of hope and despair: Interpreting “portraits of hope” and the “mehmet case”. Nature Genetics and Society, 30(4), 347–374. https://doi.org/10.1080/14636778.2011.592012

Brinkmann

(2017). The interview. In Denzin

Lincoln

(Eds.), The SAGE handbook of qualitative research (pp. 576–599). SAGE Publications.

10.

Bryson

Bogart

Atwood

Fraser

Locke

Pugh

Zerrouk

(2021). Navigating the unknown: A content analysis of the unique challenges faced by adults with rare diseases. Journal of Health Psychology, 26(5), 623–635. https://doi.org/10.1177/1359105319828150

11.

Budych

Helms

T. M.

Schultz

(2012). How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient–physician interaction. Health Policy, 105(2–3), 154–164. https://doi.org/10.1016/j.healthpol.2012.02.018

12.

Cole

Spalding

(2008). The invisible smile: Living without facial expression. Oxford University Press. https://doi.org/10.1093/acprof:oso/9780198566397.001.0001

13.

Corrigan

P. W.

Kosyluk

K. A.

Rüsch

(2013). Reducing self-stigma by coming out proud. American Journal of Public Health, 103(5), Article e1–e7. https://doi.org/10.2105/AJPH.2012.301037

14.

de Vrueh

Baekelandt

E. R. F.

de Haan

J. M. H.

(2013). Priority medicines for Europe and the world: A public health approach to innovation. In WHO Background Paper 6.19. Rare Diseases. http://www.who.int/medicines/areas/priority_medicines/BP6_19Rare.pdf

15.

Domaradzki

Walkowiak

(2019). Medical students’ knowledge and opinions about rare diseases: A case study from Poland. Intractable & Rare Diseases Research, 8(4), 252–259. https://doi.org/10.5582/irdr.2019.01099

16.

Domaradzki

Walkowiak

(2021). Knowledge and attitudes of future healthcare professionals toward rare diseases. Frontiers in Genetics, 12, 639610. https://doi.org/10.3389/fgene.2021.639610

17.

Dunkle

Pines

Saltonstall

P. L.

(2010). Advocacy groups and their role in rare diseases research. In Posada de la Paz

Groft

S. C.

(Eds.), Advances in experimental medicine and biology: Rare diseases epidemiology (686, pp. 515–525). Springer. https://doi.org/10.1007/978-90-481-9485-8_28

18.

Dunkle

M. A.

(2014). A 30-year retrospective: National organization for rare disorders, the orphan drug act, and the role of rare disease patient advocacy groups. Orphan Drugs: Research and Reviews, 4, 19–27. https://doi.org/10.2147/ODRR.S41070

19.

Dunn

Burcaw

(2013). Disability identity: Exploring narrative accounts of disability. Rehabilitation Psychology, 58(2), 148–157. https://doi.org/10.1037/a0031691

20.

Dunn

D. S.

Andrews

E. E.

(2015). Person-first and identity-first language: Developing psychologists’ cultural competence using disability language. American Psychologist, 70(3), 255–264. https://doi.org/10.1037/a0038636

21.

Earnshaw

V. A.

Quinn

D. M.

(2012). The impact of stigma in healthcare on people living with chronic illnesses. Journal of Health Psychology, 17(2), 157–168. https://doi.org/10.1177/1359105311414952

22.

Field

M. J.

Boat

T. F.

(2010). Profile of rare diseases. In Rare diseases and orphan products: Accelerating research and development. The National Academies Press. https://doi.org/10.17226/12953

23.

H. Res. 1154, 115th Cong . (2018). Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases. https://www.congress.gov/bill/115th-congress/house-resolution/1154

24.

Jaeger

Röjvik

Berglund

(2015). Participation in society for people with a rare diagnosis. Disability and Health Journal, 8(1), 44–50. http://www.ojrd.com/content/8/1/22

25.

Klitzman

(2010). Views of discrimination among individuals confronting genetic disease. Journal of Genetic Counseling, 19(1), 68–83. https://doi.org/10.1007/s10897-009-9262-8

26.

Krueger

R. A.

Casey

M. A.

(2009). Focus groups: A practical guide for applied research (4th ed.). Sage.

27.

Lemke

(2015). Patient organizations as biosocial communities? Conceptual clarifications and critical remarks. In Wehling

Viehöver

Koenen

(Eds.), The public shaping of medical research. Patient associations, health movements and biomedicine (pp. 191–207). Routledge.

28.

Zhang

Zhou

(2021). Rare disease awareness and perspectives of physicians in China: A questionnaire-based study. Orphanet Journal of Rare Diseases, 16(171). https://doi.org/10.1186/s13023-021-01788-3

29.

Maxwell

J. A.

(2010). Using numbers in qualitative research. Qualitative Inquiry, 16(6), 475-482. https://doi.org/10.1177/1077800410364740

30.

Mohr

L. E.

(1982). Explaining social behavior: The limits and possibilities of theory and research. Jossey-Bass.

31.

Mosca

Jones

W. K.

King

K. B.

Ouyang

Redberg

R. F.

Hill

M. N.

(2000). Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Archives of Family Medicine, 9(6), 506. https://doi.org/10.1001/archfami.9.6.506

32.

Munro

Cook

A. M.

Bogart

K. R.

(2021). An inductive qualitative content analysis of stigma experienced by people with rare diseases, 1080/0887. Psychology & Health. Advance online publication. https://doi.org/10.1080/08870446.2021.1912344

33.

Orphan Drug Act . (1983). Pub. L. 97-414, as amended, 96 Stat. 2049, 21 U.S.C. § 316.20.

34.

Orphanet . (2019). About rare diseases. https://www.orpha.net/

35.

Pennell

R. L.

(2001). Self determination and self-advocacy: Shifting the power. Journal of Disability Policy Studies, Disability Policy Studies, 11(4), 223–227. https://doi.org/10.1177/104420730101100404

36.

Plackowski

Hull

J. H.

(2014). Knowledge, attitudes, and behavioral intentions toward those with Lyme disease. International Journal of Education and Social Science, 1(4), 26–30.

37.

Rabinow

(1996). Essays on the anthropology of reason. Princeton University Press. https://doi.org/10.1515/9781400851799

38.

Rare Diseases Act . (2002). Pub. L. 107-280, 116 Stat. 1988, 42 U.S.C.

39.

Res

(2018). 1154, 115th Cong. Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases. https://www.congress.gov/bill/115th-congress/house-resolution/1154

40.

Rose

Novas

(2007). Biological citizenship. In Ong

Collier

S. J.

(Eds.), Global assemblages: Technology, politics, and ethics as anthropological problems (pp. 439–463). Blackwell.

41.

Saltonstall

Scott

E. M. D.

(2017). Toward a focused, multinational, rare disease awareness initiative. In Rare diseases (pp. 7–21). Routledge.

42.

Sanges

Farhat

M. M.

Assaraf

Galland

Rivière

Roubille

Hachulla

(2020). Raising rare disease awareness using red flags, role play simulation and patient educators: Results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis. Orphanet Journal of Rare Diseases, 15(1), 1–10. https://doi.org/10.1186/s13023-020-01439-z

43.

Siegel

J. F.

Kantor

(1982). Self-advocacy: Change within the individual and the professional. Social Work, pp. 451–453.

44.

Soedirgo

Glas

(2020). Toward active reflexivity: Positionality and practice in the production of knowledge. PS: Political Science & Politics, 53(3), 527–531. https://doi.org/10.1017/S1049096519002233

45.

Test

D. W.

Fowler

C. H.

Wood

W. M.

Brewer

D. M.

Eddy

(2005). A conceptual framework of self-advocacy for students with disabilities. Remedial and Special Education, 26(1), 43–54. https://doi.org/10.1177/07419325050260010601

46.

U.S. Census Bureau . (2010). Profile of general population and housing characteristics: 2010. [2010 Demographic profile data]. https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml

47.

U.S. Census Bureau . (2011). Selected characteristics of households, by total money income (HINC-01). Current population survey, 2011 annual social and economic supplement. [Excel file]. https://www.census.gov/data/tables/time-series/demo/income-poverty/cps-hinc/hinc-01.2010.html

48.

von der Lippe

Diesen

P. S.

Feragen

K. B.

(2017). Living with a rare disorder: A systematic review of the qualitative literature, systematic review of the qualitative literature. Molecular Genetics & Genomic Medicine, 5(6), 758–773. https://doi.org/10.1002/mgg3.315

49.

Wallack

Dorfman

Jernigan

Themba

(1993). Media advocacy and public health: power for prevention. SAGE publications, inc.

50.

Wehmeyer

Bersani

Gagne

. (2000). Riding the third wave: Self-determination and self-advocacy in the 21st century. Focus on Autism and Other Developmental Disabilities, 15(2), 106–115. https://doi.org/10.1177/108835760001500206

51.

Wood

Sames

Moore

Ekins

(2013). Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery. Drug Discovery Today, 18(21–22), 1043–1051. https://doi.org/10.1016/j.drudis.2013.08.006

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.11 MB

“If not me,who?”: Awareness- and Self-Advocacy-Related Experiences of Adults With Diverse Rare Disorders

Abstract

Keywords

Get full access to this article

References

Supplementary Material